When you conduct research into diseases at cellular and molecular level, you can also discover new knowledge that may suggest other types of treatment. A number of researchers have established companies which are in the process of developing new medicines on the basis of their basic scientific research for the benefit of patients. Some of those are presented on this page.
The focus of Muna Therapeutics research is to develop small molecules that can repair dysfunction in the brain's nerve cells and in this way curb different types of dementia. In 2021 the company raised a total of 450 million DKK (EUR 60 million) in funding for its research.
The researchers in NMD Pharma are trying to develop medicine for patients who cannot move due to poor connections between the nervous system and the muscles. A number of foundations have invested DKK 280 million in the company, which is one of the biggest investments in a Danish biotech company ever.